Coronary Artery Disease Clinical Trials in Iowa City, Iowa

4 studies are recruiting for coronary artery disease in Iowa City, Iowa right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Iowa City, Iowa

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. SELUTION 4 De Novo Small Vessel IDE Trial

   Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Iowa Medical Center, Iowa City, Iowa

   Locations

   70 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05946629 on ClinicalTrials.gov

3. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Iowa, Iowa City, Iowa

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov

4. Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery

   Heart disease is the leading cause of death globally, accounting for 16% of the world's total deaths. The number of cases is expected to increase as our population ages. Heart disease also results in large economic burden. It costs the United States about $219 billion per year. Some patients have s…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   University of Iowa Hospitals and Clinics, Iowa City, Iowa

   Run by

   University of Iowa

   See if you can join NCT06207318 on ClinicalTrials.gov